ArcheOptix Biomedical

medical devices

About

ArcheOptix is advancing traumatic brain injury (TBI) care by bringing hospital-grade diagnostic precision to the point of care. Our patented NIRD® (Near‑Infrared Diffuse Reflectance) device is a lightweight, non-invasive scanner that detects acute subdural and epidural hematomas in under five minutes, with 95–98% accuracy and no radiation, gels, or shaving. Driven by our mission to improve brain health outcomes, our team blends deep expertise across neuroscience, biotech, and optics. We empower caregivers in ambulances, rural clinics, emergency departments, sports sidelines, and military settings with CT-level insight that supports faster triage, reduces unnecessary CT scans, cuts costs, and improves outcomes. Headquartered in Kingston, Ontario, ArcheOptix is Health Canada–approved, MDSAP–certified, and backed by a growing IP portfolio.

Technologies

DynECT Gmail Google Apps reCAPTCHA Gravity Forms Typekit WordPress.org Google Tag Manager Squarespace ECommerce Google Font API Apache Mobile Friendly Circle Reviews AI Remote

Keywords

medical equipment manufacturing emergency response technology medical device innovation regulatory approval remote healthcare real-time diagnostics healthcare equipment & supplies services medical devices field-deployable brain scanner nird technology biotechnology emergency medical equipment point-of-care diagnostics hematoma detection remote trauma care lightweight medical device ct-level sensitivity acute hematoma detection brain hemorrhage detection cost-effective medical solutions biophotonics emergency medical services portable ct alternative radiation-free imaging non-invasive brain scan near-infrared spectroscopy brain injury detection brain bleed detection ct-level accuracy

Location

688 McKay Street, Kingston, Ontario, Canada, K7M 7G2

Related Companies

Companies in the same industry